Top brokers name 3 ASX shares to buy today

Brokers are feeling bullish about these ASX shares…
The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia. –

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three ASX shares brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Cochlear Limited (ASX: COH)

According to a note out of Credit Suisse, its analysts have upgraded this hearing solutions company’s shares to an outperform rating with a $235.00 price target. The broker made the move on valuation grounds after its shares pulled back to a more attractive level. Credit Suisse is positive on its outlook and believes the company has been winning market share over the last few years. The Cochlear share price was trading at $191.50 at Tuesday’s close.

Goodman Group (ASX: GMG)

A note out of Macquarie reveals that its analysts have retained their outperform rating and lifted their price target on this industrial property company’s shares to $26.63. Macquarie has been looking at the property sector and remains positive on Goodman. In fact, it believes the company could upgrade its FY 2022 guidance when it releases its half year results next month. The Goodman share price was fetching $22.88 at yesterday’s close.

ResMed Inc. (ASX: RMD)

Analysts at Ord Minnett have upgraded this sleep treatment company’s shares to a buy rating with an improved price target of $37.90. According to the note, the broker believes ResMed is well-placed to deliver another strong result in FY 2022. This is due to the company taking advantage of the Philips CPAP product recall. And even when Philips has completed the recall and replacement of 5.2 million devices, the broker believes ResMed has the potential to hold onto its increased market share. The ResMed share price was last trading at $32.66.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More reading

$20,000 invested in these ASX shares 10 years ago is worth how much today?

3 ASX shares brokers have named as buys

2 excellent blue chip ASX 200 shares to buy this month

Here are the top 10 ASX shares today

Why Corporate Travel Management, Goodman, Lendlease, and Uniti shares are rising today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!